(Provided by Johnson & Johnson)
Johnson & Johnson is spending over $1 billion on a next-generation cell therapy manufacturing facility in Montgomery County, Pa. The facility will develop medicines for cancer, chronic conditions and neurological diseases, officials said.
In a statement, Joaquin Duato, chairman and CEO of Johnson & Johnson, said Pennsylvania is a good location for the plant.
“For 140 years, Johnson & Johnson has been a leading innovator in American health care, and we are honored to continue advancing that legacy in Pennsylvania,” Duato said. “By uniting scientific excellence with state-of-the-art manufacturing and strategic investment, and by working collaboratively with our communities, we are delivering for patients and creating significant opportunities for workers and families.”
U.S. Sen. John Fetterman called the investment something to celebrate.
“Pennsylvania is a leader in health care innovation with some of the very best health care workers,” Fetterman said in a statement. “Proud to see this more than $1 billion investment into Montgomery County and our commonwealth. Bringing new jobs, advanced manufacturing, and life-saving medicine to and for our communities is always something to celebrate.”
The plant is expected to create more than 4,000 construction jobs and 500 positions in biomanufacturing, officials said.
Support Manufacturing Journalism
As part of SME, a nonprofit organization established in 1932, SME Media represents and supports the entire manufacturing ecosystems, from OEM primes to small and midsize job shops. Through independent journalism, we provide readers with insights and analysis of advanced technologies, processes and news.
Our mission is to accelerate widespread adoption of manufacturing technologies and build North America’s talent and capabilities, which in turn will drive competitiveness, resiliency and national security. Your support today will help us continue to deliver engaging information that informs decisions that directly affect your business.
Subscribe to our twice-weekly, FREE newsletter for the latest manufacturing news and information, including new technologies, educational webinars, podcasts and more.